BlackRock Japan’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

BlackRock Japan’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$22K	Buy	1,769 +58	+3%	+$699	﹤0.01%	1112
2016 Q3	$23K	Buy	1,711 +429	+33%	+$4.31K	﹤0.01%	1106
2016 Q2	$9K	Buy	1,282 +369	+40%	+$2.77K	﹤0.01%	1292
2016 Q1	$6K	Hold	913	–	–	﹤0.01%	1352
2015 Q4	$6K	Buy	913 +185	+25%	+$1.21K	﹤0.01%	1323
2015 Q3	$4K	Sell	728 -4,469	-86%	-$34.4K	﹤0.01%	1232
2015 Q2	$43K	Buy	+5,197	New	+$46K	﹤0.01%	1100
2014 Q3	–	Sell	-881	Closed	-$6K	–	1375
2014 Q2	$6K	Buy	+881	New	+$6.06K	﹤0.01%	1236

Other funds holding ARIA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

BlackRock Japan's ARIA Position: Q4 2016 in Review

BlackRock Japan increased its Ariad Pharmaceuticals Inc (ARIA) stake by 3.4% in Q4 2016, buying an estimated $699 and bringing the position to 1,769 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #1112.

BlackRock Japan first reported a position in ARIA in Q2 2014 and has held it in 8 quarters since. The position peaked at $43K in Q2 2015. 200 funds tracked by Wall St. Rank hold ARIA as of Q4 2016.

BlackRock Japan held 1,769 shares of Ariad Pharmaceuticals Inc worth $22K as of Q4 2016.
BlackRock Japan bought 58 Ariad Pharmaceuticals Inc shares in Q4 2016, an estimated $699.
Ariad Pharmaceuticals Inc made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1112 holding.
BlackRock Japan first reported a position in Ariad Pharmaceuticals Inc in Q2 2014 and has held it in 8 quarters since.
BlackRock Japan's Ariad Pharmaceuticals Inc position peaked at $43K in Q2 2015.
200 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.